Is Monotherapy as Good as Polypharmacy in Long—Term Treatment of Bipolar Disorder?

Garnham J Munro A Slaney C Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation study. J Affect Disord. 2007;104:185–190.

Sachs GS Nierenberg AA Calabrese JR Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356:1711–1722.

Grof P Alda M Grof E The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Br J Psychiatry. 1993;163(Supp1 21):S16–S19.

Tohen M Chengappa KN Suppes T Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v mood stabiliser alone. Br J Psychiatry. 2004;184:337–345.

Vieta E Suppes T Eggens I Efficacy and safety of quetiapine in combination with lithium or divalprœx for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord. 2008;109:251–263.

Denicoff KD Smith-Jackson EE Disney ER Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 1997;58:470–478.

Solomon DA Ryan CE Keitner GI A pilot study of lithium carbonate plus divalprœx sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry. 1997;58:95–99.

Ahrens B Muller-Oerlinghausen B. Dœs lithium exert an independent antisuicidal effect? Pharmacopsychiatry. 2001;34:132–136.

Frye MA Ketter TA Leverich GS The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry. 2000;61:9–15.

Blanco C Laje G Olfson M Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry. 2002;159:1005–1010.

Young AH Carlsson A Olausson B A double-blind, placebo-controlled study with acute and continuation phase of quetiapine and lithium in adults with bipolar depression. Bipolar Disord. 2008;10:451.

Rybakowski JK Chlopocka-Wozniak M Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord. 2001;3:63–67.

Yatham LN Kusumakar V Calabrese JR Third generation anticonvulsants in bipolar disorder: A review of efficacy and summary of clinical recommendations. J Clin Psychiatry. 2002;63:275–283.

Bowden CL Calabrese JR McElroy SL A randomized, placebo-controlled 12-month trial of divalprœx and lithium in treatment of outpatients with bipolar I disorder. Divalprœx Maintenance Study Group. Arch Gen Psychiatry. 2000;57:481–489.

Yatham LN Kusumakar V. Anticonvulsants in treatment of bipolar disorder: A review of efficacy. In: Yatham LN Kusumakar V , editors. Bipolar disorder: A clinician's guide to treatment management. New York (NY): Taylor and Francis; 2008.

Bond D Vieta E Tohen MF Antipsychotic medications in bipolar disorder: A critical review of randomized controlled trials. In: Yatham LN Kusumakar V , editors. Bipolar disorder: A clinician's guide to treatment management. New York (NY): Taylor and Francis; 2008.

Yatham LN Paulsson B Mullen J Quetiapine versus placebo in combination with lithium or divalprœx for the treatment of bipolar mania. J Clin Psychopharmacol. 2004;24:599–606.

Brecher M Anderssen H Paulsson B. Quetiapine in the maintenance treatment of bipolar I disorder: Combined data from two long-term phase III studies. Eur Psychiatry. 2008;23:S226.

Yatham LN . Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am. 2005;28:325–347. Review.

Yatham LN . Current maintenance treatments for bipolar disorder. Paper presented at the Collegium Internationale Neuropsychoparmacologium Meeting; 2008 July; Munich (DE).

Keck PE Calabrese JR McIntyre RS Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo. J Clin Psychiatry. 2007;68:1480–1491.

Thase ME Jonas A Khan A Aripiprazole monotherapy in non-psychotic bipolar I depression. J Clin Psychopharmacol. 2008;28:13–20.

Yatham LN Kennedy SH O'Donovan C Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Consensus and controversies. Bipolar Disord. 2005;7 Suppl 3:5–69.

van der Loos M Nolen WA Vieta E. Lamotrigine as add-on to lithium in bipolar depression. Bipolar Disord. 2007;9:107.

Macfadden W Haskins T Kujawa M Adjunctive risperidone long-acting injectable is effective in delaying relapse to a mood episode in patients with frequently relapsing bipolar disorder. Biol Psychiatry. 2008;63:186S.

Berghofer A Alda M Adli M Long-term effectiveness of lithium in bipolar disorder—a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry. 2008;69:1860–1868.

Garnham J Munro A Slaney C Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation study. J Affect Disord. 2007;104:185–190.

Tondo L Baldessarini RJ Hennen J Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry. 1998;155:638–645.

Rybakowski JK Chlopocka-Wozniak M Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord. 2001;3:63–70.

Capek J. All about Doggie and Pussycat: How they kept house and all sorts of other things as well. 2nd Eng ed. Prague (CZ): Albatros Publishing House, Co Inc; 2000.

van der Loos M Mulder PG Hartong EG Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: A multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry, 2009;70(2):223–231.

Tohen M Vieta E Calabrese J Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60(11):1079–1088.

Nemeroff CB Evans DL Gyulai L Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158(6):906–912.

Vieta E Suppes T Eggens I Efficacy and safety of quetiapine in combination with lithium or divalprœx for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord. 2008;109(3):251–263.

Tohen M Chengappa KNR Suppes T Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v mood stabiliser alone. Br J Psychiatry. 2004; 184:337–345.

Macfadden W Haskins T Kujawa M Adjunctive risperidone long-acting injectable is effective in delaying relapse to a mood episode in patients with frequently relapsing bipolar disorder. Biol Psychiatry. 2008;63(7):186S.